Prime Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	47.45	63.03	182.48	41.57	187.62	185.42
Short-Term Investments	47.62	114.65	7.97	80.09	106.3	84.2
Cash & Short-Term Investments	95.07	177.68	190.44	121.67	293.92	269.62
Cash Growth	-6.56%	-6.70%	56.53%	-58.61%	9.01%	405.59%
Other Current Assets	1.73	3.61	21.44	21.31	2.7	0.96
Total Current Assets	96.8	181.29	211.89	142.98	296.62	270.58
Net Property, Plant & Equipment	137.55	146.75	71.56	36.6	48.55	15.68
Other Long-Term Assets	14.69	14.69	14.06	14.28	15.14	15.6
Total Assets	249.04	342.73	297.51	193.85	360.31	301.86
Accounts Payable	5.81	8.89	11.35	19.54	4.33	1.44
Accrued Expenses	8.98	12.6	15.9	14.11	10.69	37.19
Current Portion of Leases	8.97	8.14	3.61	9.28	11.69	7.34
Unearned Revenue	7.93	7.82	7.09	-	-	-
Other Current Liabilities	-	-	-	13.5	-	12.02
Total Current Liabilities	31.69	37.45	37.96	56.42	26.71	57.98
Long-Term Leases	103.51	108.29	37.18	4.36	17.05	3.07
Other Long-Term Liabilities	74.03	76.13	69.22	-	0.28	1.24
Total Long-Term Liabilities	177.54	184.42	106.4	4.36	17.33	4.31
Total Liabilities	209.23	221.87	144.36	60.78	44.04	62.3
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	1,019	1,009	840.36	624.41	609.85	15.16
Accumulated Other Comprehensive Income	-0.01	0.08	0	-0.02	-0.38	-0.03
Retained Earnings	-979.59	-888.35	-687.21	-491.33	-293.2	-171.38
Total Common Shareholders' Equity	39.81	120.87	153.15	133.07	316.27	-156.24
Minority Interest	-	-	-	-	-	395.8
Shareholders' Equity	39.81	120.87	153.15	133.07	316.27	239.56
Total Liabilities & Equity	249.04	342.73	297.51	193.85	360.31	301.86
Total Debt	112.48	116.43	40.79	13.63	28.75	10.41
Net Cash (Debt)	-17.41	61.25	149.65	108.03	265.18	259.21
Net Cash Growth	-	-59.07%	38.52%	-59.26%	2.30%	386.07%
Net Cash Per Share	-0.10	0.41	1.26	1.19	7.82	19.98
Book Value	39.81	120.87	153.15	133.07	316.27	-156.24
Book Value Per Share	0.23	0.81	1.29	1.46	9.33	-12.04
Tangible Book Value	39.81	120.87	153.15	133.07	316.27	-156.24
Tangible Book Value Per Share	0.23	0.81	1.29	1.46	9.33	-12.04

SEC Filings: 10-K · 10-Q